Patent · US Active

Thermostable Cas9 nucleases

US10731142B2 · kind B2 · utility

4Cited by
0References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 6, 2016
Grant dateAug 4, 2020
Priority date
Expiry dateNov 13, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y301/21
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention relates to the field of genetic engineering and more particularly to nucleic acid editing and genome modification. The present invention provides an isolated Cas protein or polypeptide fragment thereof having an amino acid sequence of SEQ ID NO: 1 or a sequence of at least 77% identity therewith, wherein the Cas protein or polypeptide is capable of DNA cleavage at a temperature in the range 50° C. and 100° C. inclusive. The invention further provides isolated nucleic acid molecules encoding said Cas9 nucleases, expression vectors and host cells. The Cas9 nucleases disclosed herein provide novel tools for genetic engineering at elevated temperatures and are of particular value in the genetic manipulation of thermophilic organisms; particularly microorganisms.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.